Therefore, we evaluated serum concentrations of CCL2, CCL4, CCL5, CXCL8, and CXCL10 and examined their associations with disease activity and clinical manifestations in patients with SLE. The gene discussed is CXCL10; the disease is systemic lupus erythematosus.